Esmaeili Shahnaz, Bandarian Fatemeh, Razi Farideh, Namazi Nazli, Esmaeili Behnaz, Sanjari Mahnaz, Tootee Ali, Saeedi Saeedeh, Rambod Camelia, Aalaa Maryam, Larijani Bagher, Nasli-Esfahani Ensieh
Diabetes Research Center, Endocrinology and Metabolism Clinical sciences Institute, Tehran University of Medical Sciences, PO Box: 1411413137, Tehran, Iran.
Personalized medicine research center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2022 Jul 6;21(2):2017-2021. doi: 10.1007/s40200-021-00932-x. eCollection 2022 Dec.
A considerable amount of research funding goes to diabetes management strategies to improve therapeutic goals and reduce the burden of diabetes. A vast amount of the budget is wasted due to unnecessary studies. A scoping review is a pivotal study to overview the available evidence and avoid research waste. In this review, we will try to find out the scope of available studies on diabetes management interventions, identify associated research gaps, and prioritize future studies.
We will carry out a study using Arksey and O'Malley's scoping review framework. We will search the Scopus and PubMed databases from 01/01/2015 till 01/01/2020. Only original articles related to pharmacological and non-pharmacological management interventions will be included. These interventional studies should be conducted on the Iranian population. After data extraction, a descriptive data analysis will be used to present information in different charts or tables. We will evaluate related published articles based on their document type, level of evidence, type of diabetes, subject area, interventions types, main findings and outcomes.
This study represents the first attempt to sum up available studies related to diabetes management interventions performed in Iran. The results of this study will be useful for all the stakeholders and policy-makers involved in diabetes research. It can help clinicians to be informed about studies on management interventions and can guide scientists eager to diabetes research to choose their future research plans based on diabetes research requirements and gaps.
大量研究资金投入到糖尿病管理策略中，以改善治疗目标并减轻糖尿病负担。由于不必要的研究，大量预算被浪费。范围综述是一项关键研究，用于概述现有证据并避免研究浪费。在本综述中，我们将试图找出糖尿病管理干预措施的现有研究范围，识别相关研究空白，并确定未来研究的优先级。
我们将使用阿克西和奥马利的范围综述框架进行一项研究。我们将搜索2015年1月1日至2020年1月1日期间的Scopus和PubMed数据库。仅纳入与药物和非药物管理干预措施相关的原创文章。这些干预性研究应在伊朗人群中进行。数据提取后，将使用描述性数据分析在不同图表或表格中呈现信息。我们将根据相关发表文章的文献类型、证据水平、糖尿病类型、主题领域、干预类型、主要发现和结果对其进行评估。
本研究首次尝试总结伊朗进行的与糖尿病管理干预措施相关的现有研究。本研究结果将对参与糖尿病研究的所有利益相关者和政策制定者有用。它可以帮助临床医生了解管理干预措施的研究情况，并可以指导渴望进行糖尿病研究的科学家根据糖尿病研究需求和差距选择他们未来的研究计划。
